As for the actual closing of the incision, staples and sutures are commonly used devices. Both methods achieve their goals but carry the potential for undesirable side effects like infection and scarring. Staples provide a quicker and more consistent solution than sutures, but sutures are less expensive in the long run. Modern developments in technology have led to the development of novel methods, like absorbable tapes and adhesive compounds. Devices like these are also made in a variety of materials.
The use of cold plasma has many advantages over more traditional techniques, such as the ability to create a watertight tissue seal, the absence of a foreign-body reaction to sutures or clips, the shortening of the surgical procedure, and the lessening of trauma. Macroscopic and histopathological assessments of wound healing in a new research of incisions made into porcine skin found similar and positive outcomes. Wound inspection revealed no signs of infection, epidermal damage, bleeding, or dehiscence.
Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/50
Choosing the right method or tool is crucial for successful treatment
The Food and Drug Administration has approved BioWeld1, developed by the Israeli firm IonMed, as a new method for closing surgical incisions using cold plasma. Plasma has demonstrated a wide range of useful properties, including tissue welding, improved tissue repair, , reduced bleeding, and disinfection, the destruction of cancer cells. But the high temperature of plasma has negative effects on body tissues. Therefore, IonMed’s scientists devised a method of using cold plasma to seal wounds in a way that is both effective and safe. The procedure only takes a short time but results in minimal scarring. The bioadhesive tape, known as Chitoplast strips, included with the device makes it ideal for use in skin graft procedures. Plasma and bioadhesive work together to set the stage for the body’s natural repair mechanisms.
Clinical trials for IonMed’s BioWeld1 were concluded in 2015, and the device was granted CE mark in 2014. After receiving CE approval, the product’s applications will expand to include skin grafts and trauma wounds. The product has found success in the US market and is poised for widespread distribution across Europe.
Experts at the innovation commercialization firm Trendlines Group estimate that five million skin graft procedures are performed each year in the European Union. Furthermore, in the United States, incision closures are performed as part of nearly 70 million annual surgeries. In addition, there are about 5.89 million surgeries in the United Kingdom where wound – healing devices could be used. Possible breakthrough for cold plasma surgery incision device if even a small fraction of these operations begin using it. Due to their many benefits over traditional staples and sutures, cold plasma bio-welding devices such as BioWeld1 have a tremendous amount of potential.
Companies like Ethicon, Inc., Baxter International, Inc., 3M Company, Covidien PLC, Coloplast A/S, and Smith & Nephew, which are already well-established in the global market for CPBD (cold plasma bio-welding device), will need to develop innovative new technologies in order to remain competitive.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/50
Cold plasma could prove to be beneficial in expediting wound closure, tissue healing, attaining positive outcomes and providing sufficient tensile strength. Continuous investment is required to make the cold plasma bio-welding device BioWeld1, widely available.
To increase their product offerings, major market players are concentrating on securing new product approvals. For example, in August of this year, the Food and Drug Administration (FDA) of the United States gave the green light to human trials of the “Canady Helios Cold Plasma System and Scalpel,” a cold atmospheric plasma system developed by US Medical Innovations LLC.
Research and development on cold plasma bio-welding technology is also being conducted at prominent institutions. In September 2019, for example, scientists from the University of Antwerp in Belgium analyzed the impact of cancer type, cell type, and cell culture medium on direct and indirect cold atmospheric plasma treatment.
In a similar vein, in August of this year, scientists from the Leibniz Institute for Plasma Science and Technology reported that plasma treatment is a promising therapeutic option that does not promote metastatic behavior in pancreatic cancer cells in vitro and in ovo.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Cold Plasma Bio-welding Device Market Size Analysis from 2023 to 2030
11.6 COVID-19 Outbreak: Cold Plasma Bio-welding Device Industry Impact
Chapter 2 Global Cold Plasma Bio-welding Device Competition by Types, Applications, and Top Regions and Countries
2.1 Global Cold Plasma Bio-welding Device (Volume and Value) by Type
2.3 Global Cold Plasma Bio-welding Device (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Cold Plasma Bio-welding Device Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Cold Plasma Bio-welding Device Market Analysis
Chapter 6 East Asia Cold Plasma Bio-welding Device Market Analysis
Chapter 7 Europe Cold Plasma Bio-welding Device Market Analysis
Chapter 8 South Asia Cold Plasma Bio-welding Device Market Analysis
Chapter 9 Southeast Asia Cold Plasma Bio-welding Device Market Analysis
Chapter 10 Middle East Cold Plasma Bio-welding Device Market Analysis
Chapter 11 Africa Cold Plasma Bio-welding Device Market Analysis
Chapter 12 Oceania Cold Plasma Bio-welding Device Market Analysis
Chapter 13 South America Cold Plasma Bio-welding Device Market Analysis
Chapter 14 Company Profiles and Key Figures in Cold Plasma Bio-welding Device Business
Chapter 15 Global Cold Plasma Bio-welding Device Market Forecast (2023-2030)
Chapter 16 Conclusions
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/50
Read Our More Reports :
Pulmonary Edema Therapeutics Markethttps://www.coherentmarketinsights.com/market-insight/pulmonary-edema-therapeutics-market-4493
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027